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Objective: Vaccine hesitancy is an impediment to ﬁghting the COVID-19 pandemic. Endocrinology clinics
routinely see patients who are at high risk of a more aggressive form of COVID-19, including patients
with diabetes, obesity, and hypertension. As patients with endocrine-related conditions often require
multiple visits each year, endocrinology clinics provide a signiﬁcant opportunity for vaccine education.
The aim of our study was to evaluate patient perspectives about COVID-19 vaccination in outpatient
endocrinology clinics.
Methods: A pilot survey study of patients who visited 3 endocrinology clinics between May 31, 2021, and
June 18, 2021. A 7-item questionnaire explored the patients’ perspectives and behaviors regarding
COVID-19 vaccination. Data were analyzed with descriptive statistics.
Results: A total of 446 patients from 3 clinic locations (1 urban and 2 suburbans) completed our survey.
There were 361 (81%) patients who indicated that they were planning to or had already received the
COVID-19 vaccination, 56 (13%) reported no intent for vaccination, and 29 (7%) were unsure. Of the 85
patients who were unsure or did not intend to be vaccinated, 43 (51%) were Black, 30 (35%) were White,
and 4 (5%) had other racial/ethnic identities. When asked about vaccine hesitancy, 25 (29%) wanted to
wait and see how the others responded to the vaccine, 20 (24%) had concerns about the side effects, 12
(14%) did not believe in vaccines, and 11 (13%) felt that COVID-19 was not as bad as the media had
portrayed it. Signiﬁcantly more Black patients had vaccine hesitancy than White patients (P ¼ .035).
Conclusion: Although most endocrinology patients were amenable to COVID-19 vaccination, a subpopulation still expressed vaccine hesitancy, indicating that endocrinology clinics may be an ideal place for
targeted vaccine education.
© 2022 AACE. Published by Elsevier Inc. All rights reserved.
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Introduction
COVID-19 caused by SARS-CoV-2 was initially detected in
Wuhan, China, in December 2019. It spread rapidly throughout the
world within a month of its onset, and on March 11, 2020, the
World Health Organization (WHO) declared it a worldwide
pandemic.1 The WHO began organizing a global campaign for
prevention, early diagnosis, and medical treatment of the disease.2
More than 400 million conﬁrmed cases have been reported so far,
including more than 5 million deaths reported to the WHO as of
February 23, 2022.3 A vaccine was urgently needed to prevent

Abbreviation: WHO, World Health Organization.
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COVID-19 spread and stem complications and deaths resulting
from the transmission of the disease. The speed with which a
vaccine was developed was remarkabledfrom the publication of
the ﬁrst SARS-CoV-2 genome sequences through a phase 1 trial in
just 6 months, as compared with a typical timeline of 3 to 9 years
for the vaccine development.4 The U.S. Food and Drug Administration approved the COVID-19 vaccination under emergency use
authorization in December 2020 for individuals 16 years.5,6 The
percentage of the United States population who are now fully
vaccinated ranges from 57% to 82%.7 Considering that recent strains
of the virus causing COVID-19 are highly infectious, the proportion
of the population that must be vaccinated to reach herd immunity
could be as high as 82.5%.8
Emerging evidence in the past decade has suggested that vaccine hesitancy has been increasing across many populations, even
among health care workers.9 The WHO deﬁnes vaccine hesitancy as
a behavior inﬂuenced by several factors, including lack of
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conﬁdence in the health care system and policymakers, lack of
complacency, convenience, and risk calculation.10 Vaccine hesitancy has been recognized as a barrier to discussing disease prevention with patients since the 2009 H1N1 inﬂuenza pandemic.11,12
In the context of COVID-19, the historic speed of developing a
vaccine may have also contributed to vaccine hesitancy. Importantly, even low rates of vaccine hesitancy can have a negative
effect on public health.
Mortality from COVID-19 is higher in older adults aged >65
years, obese people, and patients with various comorbidities such
as hypertension and diabetes,13-15 and many patients with these
COVID-19 risk factors routinely visit our endocrinology clinics. Our
goal was to gain an understanding of how patients who visit our
endocrinology clinics view the COVID-19 vaccination and to elucidate the factors underlying vaccine hesitancy. We also aimed to
determine whether patient characteristics such as race and
ethnicity were associated with speciﬁc perspectives on the COVID19 vaccination, including vaccine hesitancy. Knowing patients’
perceptions about vaccines and deﬁning barriers that patients may
have to cross while receiving vaccination will be crucial for developing effective patient education initiatives to increase the vaccination rates.

Highlights
 Two in 10 patients have COVID-19 vaccine hesitancy
 Vaccine hesitancy is significantly higher in Black American patients
 Endocrinology clinics may be an ideal place for targeted
vaccine education
Clinical relevance
Several factors contribute to vaccine hesitancy. It is important to identify and address these factors to increase the
vaccination rates. This will lead to lower health care costs
and rates of COVID-19 mortality in the United States.

A total of 85 (19%) patients indicated that they were unsure or
not planning to get a COVID-19 vaccine, and we questioned the
reasoning behind this decision. Of these 85 patients, 25 patients
(29%) wanted to see how everyone else does before taking it; 20
(24%) reported fear of side effects; 11 (13%) felt that COVID-19 was
not as bad as its portrayal in the media, and 12 patients (14%) did
not generally believe in vaccines (Fig. 2). We included an option for
patients to write in their reasons for getting vaccinated. The varied
responses included concerns about fertility, already taking too
many medications, feeling they were not healthy enough to receive
the vaccine, waiting for FDA approval, presence of allergies, and
having had COVID-19 in the past.
Of the 85 patients who reported vaccine hesitancy, 43 (51%)
identiﬁed as Black, 30 (35%) as White, 5 (6%) as Middle Eastern, 2
(2%) as Asian, 1 (1%) as Hispanic, and 4 (5%) as others. Moreover,
more Black patients (23%) than White patients (14%) reported that
they were hesitant to receive a COVID-19 vaccine (P ¼ .035). While
16 of the 85 patients with vaccine hesitancy (19%) had visited a
suburban clinic, 69 (81%) had visited the downtown location.
However, more patients who visited the downtown location
participated in the survey. Assessment by the clinic location
showed that 16 of the 108 (15%) patients who visited a suburban
clinic and 69 of the 338 (20%) who visited the urban location had
vaccine hesitancy; however, these rates were not signiﬁcantly
different (P ¼ .197; Table 2).

Methods
The study was conducted in 3 endocrinology clinics in southeast
Michigan that saw patients falling within 3 high-risk groups (eg,
obesity, hypertension, and diabetes). The study was approved by
the Henry Ford Hospital Institutional Review Board. Our hospital
has a level I trauma center and also provides acute, specialty, and
preventive care services to the entire population of southeast
Michigan. Our endocrinology group examines a wide variety of
patients at the main downtown location and in 2 other locations in
surrounding suburbs. We surveyed patients in all 3 locations to
obtain patients’ perspectives from different health system locations, which may reﬂect differences in their socioeconomic status.
Based on geographic zip code data, suburban clinics had higher
income as compared with urban clinics.
We developed a 7-item questionnaire that was offered to all
patients attending our endocrinology clinics from May 31, 2021, to
June 18, 2021 (Supplementary Appendix 1). The survey had an
introduction explaining the purpose of our study and noted that
participation was voluntary and that no personal identifying information would be collected. Medical assistants distributed paper
questionnaires and collected responses within 5 minutes while
patients were waiting to be examined by the health care provider.
Patients were considered vaccine-hesitant if they answered no or
were unsure of the question about receiving a vaccine. We used
descriptive statistics to analyze and present data. The data were
collected in a Microsoft Excel ﬁle and then imported into Sigma Plot
(version 14.5; Systat Software, Inc.) for further analyses. Since all
the data are expressed in proportions, we used c2 analysis with
Fisher exact text as necessary. P < .05 denoted statistical
signiﬁcance.

Discussion
In this pilot survey study, we surveyed patients at 3 endocrinology clinics about their attitudes toward the COVID-19 vaccination. Our results showed that while >80% of the patients had
Table 1
Characteristics of Endocrinology Clinic Patients
Characteristics (N ¼ 446)
Clinic Location
Urban
Suburban
Race/Ethnicity
Asian
Black
Hispanic
Middle Eastern
Others
White
Did not answer

Results
A total of 446 patients participated in the survey. Of these patients, 108 (24%) were seen in the 2 suburban clinics and 338 (76%)
were seen in the urban clinic (Table 1). Of all the patients, 361 (81%)
reported that they were planning to or had already received the
COVID-19 vaccination. There were 29 (7%) patients who reported
that they were unsure of vaccination whereas 56 (13%) of patients
reported that they did not plan on getting the vaccine. (Fig. 1)
2

Number (%)
338 (76)
108 (24)
13
190
10
13
7
208
5

(13)
(43)
(2)
(3)
(1)
(47)
(1)
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Table 2
Characteristics
Hesitancy

of

Endocrinology

Characteristics (N ¼ 85)
Clinic Location
Urban
Suburban
Race/Ethnicity
Asian
Black
Hispanic
Middle Eastern
Others
White

Patients

Indicating

Vaccine

Number (%)
69 (81)
16 (19)
2
43
1
5
4
30

(2)
(51)
(1)
(6)
(5)
(35)

patients observed in our clinics had multiple comorbidities that
increased the risk of severe COVID-19.
Our study showed that more than half of the patients who were
hesitant to take the COVID-19 vaccination were Black, which was
signiﬁcantly higher than that of White patients. Although Black
individuals comprise only 13.4% of the U.S. population, they
account for >20% of COVID-19-related deaths.18,19 Inequities
affecting Black Americans are believed to stem from systemic
racism, which has led to higher levels of social risk factors such as
unstable housing conditions, homelessness, poverty, lower wages,
and higher risk employment as most of them are forced to put
themselves and their families at risk for COVID-19 infection. These
patients are also associated with a greater prevalence of underlying
health conditions, such as hypertension, diabetes, and obesity.20
Medical mistrust is also high among Black patients leading to
high rates of vaccine hesitancy.21
We also observed that while more patients visiting an urban
clinic had vaccine hesitancy than those who visited suburban
clinics, the difference was not statistically signiﬁcant. This observation might indicate an underlying trend of urban in comparison
with suburban rates of vaccine hesitancy, but more studies are
needed to further validate it. We did not collect data on socioeconomic factors, so we cannot determine if there is a role of these
factors in vaccine hesitancy.
There were several limitations as can be expected in a pilot
study. As the COVID-19 vaccination availability was limited at the
time we submitted our institutional review board application,
some patients did not sign up for the vaccine at the time of our
study. However, by the time our study was approved, the vaccine
had become readily available to all adult populations; we do not
believe that the study timing affected our results. We did not assess
patients from the general population, patients attending primary
care clinics, or patients who did not seek consultation in our
endocrinology clinics, which might explain the high vaccine
acceptance rate in our pilot study. Despite this possible selection
bias, our ﬁndings are useful for physicians, since knowing the
perspectives of different patient groups will help lead discussions
for further clinical improvement. Another limitation is that we did
not collect other demographic and physical characteristics such as
weight, sex, and age, as these variables may also play a role in patient perspectives on vaccines. Of all the 446 patients, 76% were
from the urban location and 24% from the suburban location. Data
were not collected including the number and type of patients
approached for participation. Also, one of our suburban clinics was
a recent addition that explains the participation of only a few patients in our study from the suburban clinics. Finally, the catchment
area of the urban and the suburban clinics are of diverse socioeconomic status, which could affect the individual perception, we,
unfortunately, did not collect this important information.
Overall, our pilot study showed a positive patient perspective on
COVID-19 vaccination at our endocrinology clinics. Although

Fig. 1. Endocrinology clinic patient responses regarding intent to receive COVID-19
vaccination. The ﬁgure shows responses (yes, no, unsure) to the question, “Do you
plan on getting a COVID-19 vaccine once available to you / Have you already gotten the
vaccine?” Percentages were calculated from a total of N ¼ 446 responses.

received or planned to receive a COVID-19 vaccine, almost 20% of
them developed vaccine hesitancy. We also found that in our
endocrinology patient population, Black patients were more likely
to express COVID-19 vaccination hesitancy than White patients.
Outbreaks of vaccine-preventable diseases are occurring at an
alarming rate in the United States, especially in geographic pockets
with poor immunization rates.16 Vaccine skepticism is a complex
issue that has led to the rise of vaccine-preventable diseases, such
as the measles outbreak in 2019. The historic speed with which the
COVID-19 vaccination was developed is one factor that has led to
vaccine hesitancy. In the United States, COVID-19 vaccination
acceptance was found to range from 60% to 79% in all 5 surveys
among the general population,17 and the rate of vaccination
acceptance that we observed was higher than that rate. We suspect
that this may be related to our at-risk patients having better vaccine
counseling through practice-wide systematic effort since most

Fig. 2. Endocrinology patient responses regarding reasons for not receiving the COVID19 vaccination. The ﬁgure shows responses to the question, “If you are not planning to
take the COVID-19 vaccination, what is your reasoning?” Responses are shown in the
ﬁgure. A total of 85 patients responded to this question, which was interpreted as
“vaccine hesitancy.”
3
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multiple factors contribute to vaccine hesitancy, clarity is required
regarding the drivers of this phenomenon and to develop interventions to combat this. There is still much room for future
research on this topic, especially patient-driven approaches for
helping our patients overcome vaccine hesitancy. The higher rate of
vaccine hesitancy observed in our Black patients suggests a need for
better health education initiatives for this population.
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